Pharmacogenomics logo Future Medicine logo

Pharmacogenomics provides the community with an essential resource for keeping abreast of the latest developments in new pharmacogenomic initiatives, emerging technologies for accessing genomic information and the development of novel diagnostic products and strategies.

Publisher: Future Medicine

Volume 8, Number 4, April 2007
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

Primum non nocere: adverse drug events must be taken seriously
pp. 311-314(4)
Authors: Gurwitz, David; McLeod, Howard L

Bulletin Board

It's ALL in the genes
pp. 315-317(3)

Research Report

Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan
pp. 319-327(9)
Authors: Vincenzi, Bruno; Santini, Daniele; Russo, Antonio; Gavasci, Michele; Battistoni, Fabrizio; Dicuonzo, Giordano; Rocci, Laura; Rosaria, Valerio Maria; Gebbia, Nicola; Tonini, Giuseppe

Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients
pp. 329-337(9)
Authors: Cho, Hyun-Jung; Sohn, Kie-Ho; Park, Hyang-Mi; Lee, Kyung-Hoon; Choi, BoYoung; Kim, Seonwoo; Kim, June-Soo; On, Young-Keun; Chun, Mi-Ryung; Kim, Hee-Jin; Kim, Jong-Won; Lee, Soo-Youn

Review

Analytical validation of genotyping assays in the biomarker laboratory
pp. 353-368(16)
Authors: Isler, Jennifer A; Vesterqvist, Ole E; Burczynski, Michael E

Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine
pp. 369-390(22)
Authors: Kaput, Jim; Perlina, Alla; Hatipoglu, Betul; Bartholomew, Amelia; Nikolsky, Yuri

Perspective

Human rights and ethics in genomic research: rethinking the model
pp. 391-395(5)
Author: Ashcroft, Richard E

Company Profile

Genomic Health, Inc.
pp. 397-399(3)
Author: Baker, J

Iconix Biosciences, Inc.
pp. 401-405(5)
Authors: Fielden, Mark R; Halbert, Donald N

Obituary

Special Report

Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trials
pp. 409-414(6)
Authors: Kebba, Anthony; Imami, Nesrina; Bugembe-Lule, Daniel; Senkaali, David; Kaleebu, Pontiano; Grosskurth, Heiner; Gotch, Frances

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A